Insertion Turbine Flowmeters
Titan Enterprise's innovative insertion turbine flowmeters combine proven robust technology with modern materials and design.
The Polyvinylidene Fluoride (PVDF) turbine on insertion turbines rotates freely on a 316 stainless steel shaft and has specially aerofoil shaped blades to extend the dynamic range of the meter. The specially contoured housing further improves the meters linearity particularly at lower fluid velocities. Each meter contains two sensors, one self-powered (for battery operated equipment) and the other an open collector transistor. A reed switch may be specified for hazardous areas were simple apparatus is acceptable. The body is manufactured from AISI316 stainless steel and as standard is supplied with three metres of five core screened instrument cable.
These insertion turbines provide a cost effective and simple means to measure the flow of a wide range of low viscosity liquids. Installation is quick and inexpensive in pipes from 40 mm diameter up to 900 mm diameter. Due to the relatively small disturbance a Titan insertion flow meter head introduces to a pipe, pressure losses for this type of flowmeter are very low delivering significant energy savings by reducing pumping costs. For rate and total applications, Titan offers self-powered instruments (MetraCount, MetraSmart) that can be mounted directly onto the insertion turbine meter to enable stand-alone measurement.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.